USNA: USANA Health Sciences Inc

USNA Nouvelles

• 13:40 Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?
• 15:40 USNA vs. SDZNY: Which Stock Is the Better Value Option?
• 13:40 Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
• 09:08 United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last?
• 18:43 EHC Stock: Do Valuation and Expansion Trends Support a Hold Strategy?
• 16:59 JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study
• 19:05 Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
• 12:23 RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study
• 17:05 RLMD Stock Surges 42% in a Week: Here's What You Should Know
• 15:40 USNA or ZTS: Which Is the Better Value Stock Right Now?
• 15:09 EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y
• 13:35 USANA Health (USNA) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
• 14:23 Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study
• 14:57 QURE Stock Crashes 32% in a Week: Here's What You Should Know
• 14:45 TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS
• 13:17 5 Low P/B Ratio Stocks That You May Consider Buying in March
• 14:55 USANA Health (USNA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
• 14:18 CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data
• 12:27 4 Value Stocks to Buy as Middle East Tensions Keep Markets on Edge
• 10:07 ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)
• 06:03 USANA Looks Like An Undervalued Turnaround Stock (NYSE:USNA)
• 13:03 ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU
• 06:58 Le directeur informatique de Usana Health Sciences, Benedict Peter, vend pour 88.258$ d’actions
• 06:58 Usana Health Sciences CIO Benedict Peter sells $88,258 in stock